OncoTherapy Science Inc. / OTS / Corporate Communications Department Shionogi & Co. Ltd. / Shionogi & Co. Ltd. / /
Country
Japan / /
Event
Business Partnership / / /
IndustryTerm
gene products / treatment of patients with several types of cancers / foreign healthcare reforms / treatment of the diseases / with respect to product / /
MedicalCondition
cancers / tumor / market cancer / Cancer / diseases / esophageal cancer / bladder cancer / /
MusicAlbum
President / Ph.D. / /
Person
Isao Teshirogi / Takuya Tsunoda / / /
Position
President and CEO Head Office / President & CEO / Chief Executive / /
Shionogi Enters into Exclusive Licensing Agreement with OncoTherapy Science to Develop and Market Cancer Peptide Vaccines Osaka, Japan, March 30, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Tes